AGP Picks
View all

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on July 1, 2026

Inaugural Juneteenth Exchange Draws 150+ Executive Leaders, Spotlights Rancho Cordova's Innovation Hub
K2 Foundation Unveils New Brand Identity and Global Impact Strategy Following K2 Group's Evolution
Grand Butterfly Gathering 2026 Soars Across Continents, Celebrating 'Wings of Purpose' Through Global Unity and Action
iPlan Global and Levridge - Strategic Partnership to Transform Agribusiness and Grain Value Chains Across Africa
La Côte d’Ivoire franchit une étape historique en matière de financement climatique agricole
Côte d'Ivoire secures major climate finance to support smallholder farmers adapt to climate change and increase yields
NoOnes Partner Rewards Returned to Users Increased by over 400% in 12 Months
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Chartered Institute Launches the Chartered International Project Leader (CIPL™) To Advance Global Project Execution
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
MedPreneur Launches AI-Powered Platform for Medical and Health-Related Students Worldwide
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
Introducing Siris Broker — a Mauritius FSC-licensed CFD and FX brokerage purpose-built around client experience.
ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
Creative Medical Technology Holdings Issues Mid-Year Update
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Africa Gazette

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.